Join to View Full Profile
89 French StNew Brunswick, NJ 08901
Phone+1 732-235-4980
Fax+1 732-235-5002
Dr. Horton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Daniel B. Horton, MD, MSCE is a pediatric rheumatologist based in New Brunswick, NJ. He completed his medical education at Harvard Medical School in 2008, followed by a Pediatrics Residency at the Children's Hospital of Philadelphia and a Pediatric Rheumatology Fellowship at Nemours Children's Health in Wilmington, Delaware. Dr. Horton performs research in a variety of areas, including research on juvenile idiopathic arthritis, pediatric medication use and safety, child health, team science, and COVID-19.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Nemours Children's Health, WilmingtonFellowship, Pediatric Rheumatology, 2011 - 2014
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2008 - 2011
Harvard Medical SchoolClass of 2008
Certifications & Licensure
NJ State Medical License 2016 - 2025
DE State Medical License 2011 - 2017
PA State Medical License 2008 - 2013
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Rheumatology
Publications & Presentations
PubMed
- Trends in New Use of Disease-Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022.Priyanka Yalamanchili, Lydia Y Lee, Greta Bushnell, Melissa L Mannion, Chintan V Dave
Arthritis & Rheumatology. 2025-04-01 - 1 citationsPediatric Pharmacoepidemiology and Drug Development From a Regulatory Perspective.Ann W McMahon, Daniel B Horton, Yeruk Mulugeta, Lynne Yao
Clinical Pharmacology and Therapeutics. 2025-04-01 - 1 citationsPopulation-Based Validation Results From the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) Study.Rishi J Desai, Vijay R Varma, Mufaddal Mahesri, Su Been Lee, Ariel Freedman
Clinical Pharmacology and Therapeutics. 2025-04-01
Press Mentions
- A Reason to Mask Sick Kids? Rutgers Study Cites Asthma Declines During PandemicApril 4th, 2023
- Merck's COVID Pill Shows 'Modest' Benefit in High-Risk OutpatientsDecember 16th, 2021
Health Care Workers Have a Higher Prevalence of COVID-19 Than Non-Health Care WorkersNovember 16th, 2020- Join now to see all
Grant Support
- Safety of Drugs Commonly Used Off-Label in Children Despite Insufficient Evidence of Efficacy and SafetyRUTGERS BIOMEDICAL AND HEALTH SCIENCES2022–2027
- Safety of Drugs Commonly Used Off-Label in Children Despite Insufficient Evidence of Efficacy and SafetyRUTGERS BIOMEDICAL AND HEALTH SCIENCES2022–2027
- New Jersey ECHORUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2025
- Cohort and biomarkers for COVID-19 severity, natural history, and reinfectionRUTGERS BIOMEDICAL AND HEALTH SCIENCES2021–2025
- Antibiotics, Juvenile Idiopathic Arthritis, and Antirheumatic Treatment ResponseRUTGERS BIOMEDICAL AND HEALTH SCIENCES2019–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
